| Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc |
| Journal website http://www.neurores.org |
Letter to the Editor
Volume 10, Number 5, October 2020, pages 203-206
COVID-19-Related Acute Ischemic Stroke in Young Adults: What Is the Optimal Antithrombotic Regimen for Secondary Prevention?
Table
| Authors | Country | Type of article | Age (years)/sex | Secondary prevention | |
|---|---|---|---|---|---|
| M: male; F: female; NR: not reported. | |||||
| 1 | Yaghi et al, 2020 [2] | USA | Case Series | 40, 40, 50, 50, 50; sex: NR | Anticoagulant |
| 2 | Oxley et al, 2020 [3] | USA | Case series | 33/F; 37/M | Apixaban 5 mg twice daily |
| 3 | Fara et al, 2020 [4] | USA | Case series | 33/F | Aspirin plus clopidogrel then switched to apixaban 5 mg twice daily |
| 4 | Ashrafi et al, 2020 [8] | Iran | Case series | 33/F; 39/M; 40/M | Aspirin plus clopidogrel |
| 5 | Deliwala et al, 2020 [9] | USA | Case report | 31/F | Aspirin |
| 6 | Reddy et al, 2020 [10] | USA | Case series | 47/M; 39/F | Antiplatelet |
| 7 | Franceschi et al, 2020 [11] | USA | Case series | 33/M; 37/F | Anticoagulant (one of them received argatroban) |
| Total | 16 patients | Anticoagulant: 10; dual antiplatelet: 3; single antiplatelet: 3 | |||